|
|
Home
| Databases
| WorldLII
| Search
| Feedback
Papua New Guinea Consolidated Legislation |
Chapter 231.
Poisons and Dangerous Substances Act 1952.
Certified on: / /20 .
INDEPENDENT STATE OF PAPUA NEW GUINEA.
Chapter 231.
Poisons and Dangerous Substances Act 1952.
ARRANGEMENT OF SECTIONS.
INDEPENDENT STATE OF PAPUA NEW GUINEA.
AN ACT
entitled
Poisons and Dangerous Substances Act 1952,
Being an Act relating to the control, sale and use of poisons, drugs and dangerous substances and articles used in medicine and surgery, and for related purposes.
PART I. – PRELIMINARY.
(1) In this Act, unless the contrary intention appears–
“automatic machine” means a machine or mechanical device that is used, or is capable of being used, for the purpose of selling goods without the personal manipulation or attention, at the time of the sale, of the seller or of an employee or agent of the seller;
“the British Pharmacopoeia” means the British Pharmacopoeia as published in the United Kingdom under the direction of the General Medical Council of the United Kingdom, in the edition for the time being in force;
“container”, in relation to a substance, material, body or thing referred to in this Act, means a vessel, bottle, tube, tin, box, case, wrapper, cover or other similar receptacle or envelope that immediately contains the substance, material, body or thing;
“dangerous substance” means a thing specified in Schedule 4 or 5;
“methylated spirit” includes–
(a) spirit that has been methylated or denatured; and
(b) methyl alcohol and wood spirit; and
(c) any other spirit to which a methylated substance has been added; and
(d) any potable liquid with which methylated spirit is mixed;
“package” includes a case, bottle, jar, vessel, bag, box or other receptacle, and any other means by which goods are cased, covered, enclosed, contained or packed;
“poison” means a thing specified in Schedule 1, 2 or 3;
“poisons licence” means a licence under Section 5;
“Poisons Register” means register in accordance with Section 16;
“rectified spirit” means rectified spirit as defined in the British Pharmacopoeia;
“the regulations” means any regulation made under this Act;
“sell” includes–
(a) sell, whether by wholesale or retail, and barter or exchange; and
(b) supply; and
(c) deal in; and
(d) agree to sell; and
(e) offer or expose for sale; and
(f) keep or have in possession for sale; and
(g) send, forward, deliver or receive for sale or on sale; and
(h) authorize, direct, cause, permit or attempt any act or thing referred to in Paragraph (c), (d), (e) or (f);
“this Act” includes the regulations.
(2) Without restricting the meaning of the word “possession”, a substance shall, for the purposes of this Act, be deemed to be in the possession of a person so long as it is on land or premises occupied by him, or is used, enjoyed or controlled by him in any place, unless it is shown that he had no knowledge of that fact.
This Act does not apply to the State or to an officer while acting in his official capacity.
For the purposes of this Act, in the case of liquid preparations percentages shall be calculated on the basis that a preparation containing 1% of any substance means a preparation in which–
(a) if a solid–1g of the substance; and
(b) if a liquid–1ml of the substance,
is contained in every 100ml of the preparation, and so in proportion for any greater or less percentage.
The Minister may, by notice in the National Gazette, delete any item from, vary any item in, or add an item to, a schedule, and from the date of the publication of the notice that schedule shall be read subject to the deletion, variation or addition made by the notice.
PART II. – LICENCES.
(1) The Minister may grant a poisons licence to a person to sell a poison specified in Schedule 3 for one year from the date of the licence.
(2) The fee for a licence is as prescribed.
(3) On payment of the prescribed fee, the holder of a poisons licence may have his licence renewed, from time to time, for a period of one year.
(4) A poisons licence shall specify the place or places at which the holder may sell poisons, and does not authorize him to sell poisons at any other place.
(1) A poisons licence may be revoked by the Minister at any time.
(2) Where a person is convicted of an offence against this Part in relation to methylated spirit as defined in the British Pharmacopoeia, or rectified spirit, the court that convicts him may, in addition to or in substitution for any other penalty–
(a) cancel, vary or restrict a licence granted to him under this Act; and
(b) cancel, vary or restrict any other licence or permit to purchase, sell or deal in any goods or commodities granted to him under any other law,
if the court, having regard to the nature of the offence, thinks it desirable to do so in the public interest.
PART III. – SALE OF POISONS AND DANGEROUS SUBSTANCES.
This Part does not apply to the sale of poisons by wholesale dealers in the ordinary course of wholesale dealing, where–
(a) a written order signed by the purchaser is given for the supply of the poison; and
(b) the vendor at the time of the sale and before delivery enters in a book to be kept for the purpose the nature and quantity of the poison and the name and place of residence of the purchaser.
A person, other than a medical practitioner, a pharmacist or a person specially licensed by the Minister to do so, must not sell a thing specified in Schedule 1 or 2.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months or both.
(1) Subject to Subsection (2), a person must not sell a thing specified in Schedule 1 except on the prescription or on the written order of a medical practitioner, a dentist or a veterinary surgeon.
(2) Notwithstanding Subsection (1), the Departmental Head may authorize the sale or distribution of things specified in Schedule 1 to persons required to be in possession of such things under any law.
(3) Unless the prescription or order referred to in Subsection (1) expressly states that a thing specified in Schedule 1 is to be supplied more than once, a person–
(a) must not sell any such thing more than once on the same prescription or order; and
(b) must, after selling the thing, write the word “Cancelled” and his name and the date on the prescription or order.
(4) If the prescription or order states that the thing specified in Schedule 1 is to be supplied for a maximum number of times–
(a) a person selling that thing must, on the occasion of each sale, write his name and the date on the prescription or order; and
(b) the person who sells the thing on the last occasion, as determined by the maximum number of times of supply so stated and evidenced by the writing on the prescription or order, must, in addition to writing the particulars required by Paragraph (a), write the word “Cancelled”.
(5) A person must not supply a thing specified in Schedule 1 on a prescription or order on which the word “Cancelled” is written.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A person other than a medical practitioner, a pharmacist or the holder of a poisons licence must not sell a thing specified in Schedule 3.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
Subject to this Act and to any other law, any person may sell a thing specified in Schedule 4.
(1) Subject to this Act and to any other law, any person may sell to a purchaser who is known to the vendor to be engaged in mining, agriculture, horticulture or the keeping or breeding of animals a thing specified in Schedule 5 that is packed exclusively for the purpose of the industry in which the purchaser is engaged.
(2) Where a thing referred to in Subsection (1) is labelled and packed as required by this Act and is sold in the quantity set out in Schedule 5, it shall, for the purposes of this Act, be deemed to be specified in that Schedule and not in any other Schedule notwithstanding that it, or some of its component parts, is in fact specified in any other Schedule.
A person who–
(a) sells or offers for sale in a street or public place, or from house to house; or
(b) hawks or peddles, or distributes or causes to be distributed as samples, in a street or public place, or from house to house,
a poison or dangerous substance is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
(1) Subject to Section 21, a person who sells a poison to a person who is under 18 years of age is guilty of an offence.
(2) Subject to Section 21, a person who sells a poison to a person who is unknown to the vendor is guilty of an offence unless the sale is made in the presence of a witness who is known to the vendor and who knows the purchaser.
(3) Before the delivery to the purchaser, the witness in whose presence a sale to which Subsection (2) applies is made must sign the entry adding his name and place of residence as required by this Part.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A person who–
(a) installs an automatic machine for the sale of a poison or dangerous substance; or
(b) sells a poison or dangerous substance by means of an automatic machine,
is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A pharmacist or the holder of a poisons licence must keep a Poisons Register in which he must enter from time to time all information that he is required by this Part to enter.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
Subject to Section 21, except where a sale is made under Section 19, a person, other than a medical practitioner, who sells a thing specified in Division 1 of Schedule 2, or in Schedule 3, must, before delivery of the thing to the purchaser–
(a) enter in the Poisons Register–
(i) the name, place of residence and occupation of the purchaser; and
(ii) the date of purchase; and
(iii) the description and quantity of the thing purchased; and
(iv) the purpose for which the thing is required; and
(b) sign, and ensure that the purchaser and witness (if any) required by this Act to be present, sign the entry in the Poisons Register.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
Subject to Section 21, a person who sells a thing specified in Division 1 of Schedule 2, or in Schedule 3, to a person who is unable to sign his name is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
(1) Subject to this Act, a pharmacist or the holder of a poisons licence may sell a thing specified in Division 1 of Schedule 2, or in Schedule 3, on receipt of an order–
(a) by letter, where–
(i) the vendor is familiar with the signature of the purchaser; or
(ii) the signature has been witnessed by a District Officer, a commissioned officer of the Police Force or a person known to the vendor,
and the letter is preserved by the vendor for a period of two years; or
(b) by telegram or radiogram, where the purchaser is known to the vendor and the telegram or radiogram is preserved by the vendor for a period of two years.
(2) In the case of a sale referred to in Subsection (1), unless the sale conforms with the other provisions of this Act the vendor must make an entry in the Poisons Register stating–
(a) the date of the letter, telegram or radiogram; and
(b) by whom it was written or sent; and
(c) the nature and quantity of the thing ordered.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months or both.
(1) A medical practitioner, dentist or veterinary surgeon is not required to sign an entry in the Poisons Register in respect of a purchase by him if the vendor–
(a) before or within 24 hours after the delivery of the poison receives a written order signed by the purchaser stating his name and address and the name and quantity of the poison to be purchased; and
(b) is satisfied that the signature to the order is in fact the signature of the person purporting to sign it, and that the person is a medical practitioner, dentist or veterinary surgeon, as the case may be; and
(c) enters in the Poisons Register, in the place assigned to the signature of purchasers, the words “Signed order” followed by the date on which the order is executed,
and if the vendor sends by registered post any poison that he sends by post.
(2) In a case to which Subsection (1) applies, where the signed order is not lodged with the vendor before the expiration of the period specified in Subsection (1)(a) the purchaser is guilty of an offence.
(3) Where this section applies to a purchaser of any poison, the vendor must preserve the signed order of the purchaser for a period of two years from the date on which the final entry in the Poisons Register is made.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
(1) Sections 14, 17, 18 and 19 do not apply in respect of a poison that is–
(a) compounded by a medical practitioner or a pharmacist according to the prescription of a medical practitioner; or
(b) in the form of homoeopathic medicine otherwise than in the crude state, as a mother tincture or of a strength greater than the third decimal potency; or
(c) in the form of a medicine dispensed by a veterinary surgeon or pharmacist according to the prescription for animals under treatment of a veterinary surgeon; or
(d) in the form of a mixture compounded by a pharmacist in the legitimate pursuit of his business.
(2) Notwithstanding Subsection (1), a person who sells or delivers a medicine for external application containing poison otherwise than in the prescribed type of container labelled in the prescribed manner is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
(1) A medical practitioner who prescribes or dispenses, and a pharmacist who dispenses, a medicine containing a thing specified in Schedule 1 must keep a record in a suitable book of the prescription so prescribed or dispensed by him, and the name and address of the person for or to whom it was prescribed or dispensed.
(2) The record referred to in Subsection (1) must–
(a) be readily accessible for inspection; and
(b) be preserved by the person prescribing or dispensing for a period of two years.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
PART IV. – LABELLING AND PACKING POISONS AND DANGEROUS SUBSTANCES.
A person selling a poison or dangerous substance must–
(a) keep all the poisons or dangerous substances separate and distinct from food, drugs or goods of any kind that are suitable for the food of man or animal; and
(b) deliver it to the purchaser in a package or container securely sealed and fastened; and
(c) sell it only in bottles, tins, cans, jars, drums, casks or containers of sufficient strength to bear the ordinary risk of transit without leakage; and
(d) deliver it, if sold in bottles, tins, cans, jars, drums, casks or containers, to the purchaser in a container to which is securely affixed a label on which–
(i) the words “Poison–Not to be Taken” or “Poisonous–Not to be Taken” is printed; and
(ii) the word “Poison” or “Poisonous” form the first line of the label and appear in red letters of a size larger than any other letters on the label; and
(iii) the name of the poison or dangerous substance appears; and
(iv) the name and address of the vendor appears; and
(e) have securely attached to–
(i) packages of solid poisons or solid dangerous substances; and
(ii) packages or containers of poisons or dangerous substances intended to be used for–
(A) photography; or
(B) fly-poison papers; or
(C) the destruction of rats, mice, birds or vermin; or
(D) veterinary, pastoral, agricultural, horticultural or mining purposes,
a label containing the matters required by Paragraph (d), together with a notice indicating–
(iii) the special purpose for which the poison or dangerous substance is intended; and
(iv) that the poison or dangerous substance must not be used for any other purpose; and
(f) not sell–
(i) arsenic or its preparations or paris green, or other coloured arsenical paints and pigments; or
(ii) a poison or dangerous substance intended to be used exclusively for the purpose of destroying rats, mice, birds or vermin,
in paper bags or collapsible tubes, or in cardboard containers other than cardboard containers that are impervious to the poison and sufficiently stout and sealed or fastened to prevent leakage arising from the ordinary risks of handling, storing or transport; and
(g) deliver a medicine intended for internal use containing a poison or dangerous substance to the purchaser in a package or container to which there is securely affixed a label bearing the words–
“This preparation is labelled “Poison” in conformity with the Poisons and Dangerous Substances Act, but if taken in strict accordance with the prescribed dose is not dangerous.”
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A person who sells a liquid dangerous substance specified in Schedule 6–
(a) in an area declared by the Minister, by notice in the National Gazette, for the purpose of this section, otherwise than in a tin, plastic screw- top container or triangular green or amber bottle; or
(b) in an area not declared under Paragraph (a), otherwise than–
(i) as prescribed in Paragraph (a); or
(ii) in a bottle other than a bottle the exterior of which is painted with a paint other than a waterpaint; or
(c) in a bottle or other container that is–
(i) used for packing, storing or delivering food or drink, except as permitted by Paragraph (b)(ii); or
(ii) closed with a stopper that is marked with the name of a food or drink; or
(iii) closed with a stopper other than a cork or screw-on cap,
is guilty of an offence.
Penalty: A fine not exceeding K200.00.
A person who sells methylated spirits that is not coloured blue with a non-toxic dye is guilty of an offence.
Penalty: A fine not exceeding K200.00.
(1) A poison, mercurochrome or tincture of iodine sold in a bottle must be delivered to the purchaser in a dark-blue, dark-green or dark-brown glass bottle of a round, square, diamond, triangular or other shape approved of by the Minister on which–
(a) the word “Poison” or the words “Not to be taken” are blown; and
(b) prominent points, stars, flutes or vertical ribs are blown in such a manner as to render the bottle distinguishable by touch from bottles or vessels ordinarily used as containers of food, drink or condiment, or of medicines for internal use.
(2) Subject to Subsection (3), a label must not be attached or affixed to the bottle in such a manner that the points, stars, flutes, ribs or prescribed words blown on the bottle are covered or obliterated.
(3) The label may cover the front panel of the bottle and extend around the adjacent sides if the matter blown on the back panel of the bottle and the prescribed words blown on the bottle are not covered or obliterated.
(4) A person who delivers in a bottle to a purchaser a substance referred to in Subsection (1) otherwise than in accordance with this section is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
PART V. – MISCELLANEOUS.
A person who drinks methylated spirit as defined in the British Pharmacopoeia, or rectified spirit, is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A person who sells or disposes of methylated spirit as defined in the British Pharmacopoeia, or rectified spirit, to another person, who he has reasonable cause to believe intends–
(a) to use the spirit for drinking purposes; or
(b) to give or supply the spirit to any other person for drinking purposes,
is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
For the purposes of this Act, an officer of the Department, or a commissioned officer of the Police Force, authorized in writing by the Minister, may–
(a) enter any premises; and
(b) demand the production of, and search for and inspect, any books or documents, stock of poisons or dangerous substances or thing that he suspects may be a poison or dangerous substance; and
(c) take away samples of any such poison, dangerous substance or thing.
A person who–
(a) purchases a poison or dangerous substance and gives false information to the vendor in answer to inquiries in relation to matters concerning which the vendor is entitled or required by this Act to inquire; or
(b) signs his name as a witness to the sale of a poison to a person unknown to him; or
(c) offers for sale a poison or dangerous substance in respect of which the provisions of this Act have not been observed; or
(d) refuses to produce books or documents or things when required to do so by an officer authorized by or under Section 29; or
(e) impedes or obstructs an officer authorized by or under Section 29 in the performance of his duty under this Act,
is guilty of an offence.
Penalty: A fine not exceeding K200.00 or imprisonment for a term not exceeding 12 months, or both.
A person convicted of an offence against this Act relating to–
(a) the keeping of books; or
(b) the issuing or dispensing of prescriptions issued by medical practitioners,
shall not be sentenced to imprisonment or to pay a fine of more than K200.00 if the court dealing with the case is satisfied that the offence was due to inadvertence and was not preparatory to, or committed in the course of, or in connection with, the commission or intended commission of any other offence.
The Head of State, acting on advice, may make regulations, not inconsistent with this Act, prescribing all matters that by this Act are required or permitted to be prescribed, or that are necessary or convenient to be prescribed for carrying out or giving effect to this Act, and in particular prescribing matters providing for and in relation to–
(a) the forms to be used for the purposes of this Act; and
(b) the manufacture, storage and safe custody of poisons and dangerous substances; and
(c) the colouring of a poison or dangerous substance; and
(d) the shape, size, materials and labelling of the containers or packages in which a poison or dangerous substance may be sold; and
(e) the printing on packages in which a poison or dangerous substance is packed for sale of the name of an effective remedy to counteract its effect; and
(f) the prohibition, either absolutely or except under prescribed conditions, of the supply, manufacture or distribution of a poison or dangerous substance; and
(g) the restriction or prohibition, except under prescribed conditions, of the use of any substance or thing that may be contaminated or affected by the use of a poison or dangerous substance; and
(h) the issue by medical practitioners of prescriptions containing poisons or dangerous substances and the dispensing of such prescriptions; and
(i) the control of the sale of methylated spirit and of rectified spirit; and
(j) the fees for any services or purposes under this Act, and in particular for the analysis or examination of drugs, disinfectants or preservatives; and
(k) prescribing penalties of fines not exceeding K200.00 or imprisonment for terms not exceeding 12 months, or both, for offences against the regulations.
SCHEDULE 1 – [1]POISONS, GENERAL.
Secs. 1, 8, 9, 22.
Acebutolol
Acetanilide and alkyl acetanilides
Acetazolamide
Acethexamide
Acetyl cysteine
Acetyl Methyl Dimethyl Oximido Phenyl Hydrazine
Acetylphenylhydrazine
Aconite–Root of Aconitum Napellus and substances for internal use containing more than 0.02% of the alkaloids of aconite, and liniments for external application containing more than 0.1% of the alkaloids of aconite.
Adonis Vernalis
Adrenalin, natural or synthetic, its salts, and in substances containing more than 1%
Alcofenac
Aldosterone
Allylisopropylacetylurea
Aloxidone
Alphaxolone
Alprenolol
Alseroxylon
Amantadine
Ambenonium
Amidopyrin, its salts, its derivatives and their salts
Amiloride
Aminobutyric Acid
Aminocaproic Acid
Aminoglutethimide
Aminometradine
Aminorex
Amiphenazole
Amisometradine
Amitriptylin and other compounds structurally derived, from amitriptylin
Ammidin
Anabolic Steroids and Androgens natural or synthetic
Anaesthetics–the following–when specifically prepared and packed as therapeutic agents for the induction and maintenance of inhalation anaesthesia:–
Ether, Ethyl Chloride, Ethylene, Fluroxene, Nitrous Oxide, Trichlorethylene, Vinyl Ether, Cyclopropane, Chloroform, Halothane, Methoxyflurane, Enflurane
Anaesthetics Local, being synthetic cocaine substitutes except when included in Schedule 2
Analeptics, including Bemegride, Leptazol, Picrotoxin, Nikethamide
Angiotensine Amide
Anisindione
Antibiotics, synthesized or derived from natural sources except when included in Schedule 2 or Schedule 5
Anticholine Esterases and their salts and other organophosphorus compounds with anticholine esterase activity when used for therapeutic purposes, including Neostigmine, Dyflos
Anticholinergic Substances, including Dicyclomine, Diphemanil Methyl Sulphate, Methantheline, Oxyphenonium and Propantheline Bromide, except when specifically included in Schedule 2
Anticonvulsant Substances including hydantoin derivatives, oxazolidinedione derivatives and Primidone
Antidiabetic Substances which are sulphonamide or diguanidine derivatives of urea including Carbutamide and Tolbutamide
Antifolic Acid Substances including Aminopterin, Teropterin and Orthopterin
Antihistamines, except when included in Schedule 2
Anti-leprosy Substances
Anti-malarial Substances except when specifically included in Schedule 2
Antimony Organic Compounds of, for parenteral use
Antineoplastic Agents
Antiparkinsonian Substances including Benzhexol, Caramiphen, Diethazine, Ethopropazine, Procyclidine and their salts
Antithyroid Substances including Carbimazole, Methimazole and Thiouracil and derivatives except Thiourea
Antitubercular Substances including Isoniazid and its derivatives, Para-aminosalycylic Acid and its salts, Thiacetazone, d-Cycloserine, Ethionamide and Pyrazinamide
Apomorphine
Arsenic, organic compounds of, for therapeutic use except when included in Schedule 5
Ataractic Substances including:–
(i) Phenothiazine derivatives including Chlorpromazine, Promazine and Mepazine; and
(ii) Benzilic Acid derivatives including Benactyzine and Cevanol; and
(iii) 1:3 propane diol derivatives including Meprobmate; and
(iv) Benzhydrol derivatives including Azacyclonal; and
(v) Piperazine derivatives including Hydroxyzine; and
(vi) Methylpentynol; and
(vii) Butyrophenone derivatives including Droperidol, Haloperidol, Methylperidol and Triperidol; and
(viii) Benzodiazepine derivatives including Chlorazepate, Diazepam, Flurazepam, Lorazepam, Medazepam, Nitrazepam, Oxazepam, and Chlorodiazepoxide derivatives; and
(ix) Diphenylbutyl piproxide derivatives
Atropine and substances containing more than 0.25% of the organic base except when included in Schedule 5.
Aurothioglucose
Azamethonium
Azapetine
Baclofen
Barbituric Acid, its derivatives and their salts in substances containing more than 0.2%, of barbituric acid or its derivatives and their salts
Belladonna and substances containing more than 0.25% of the alkaloids of belladonna calculated as hyoscyamine
Benzbromarone
Benziodarone
Benzitramide
Benzoctamine
Benzpryinium
Benzquinamide
Benzydamine
Benzyl-dimethyltryptamine
Beta-aminopropylbenzene (amphetamine) and Beta-aminoisopropylbenzene and any compound structurally derived from either of those substances by substitution in the side chain or by ring closure therein (or by both such substitution and such closure), except Ephedrine, N-methylephedrine, N-diethylaminoethyl-ephedrine, Phenylpropanolamine and Prepylamine; any salt of any substance falling within this item
Betahistine
Betameprodine
Betaprodine
Bethanidine
Bibenzonium Bromide
Bismuth Glycollylarsanilate
Bismuth Sodium Tartrate
Bismuth Subgallate for internal therapeutic use except in suppositories
Boron Compounds for human therapeutic or cosmetic use, except:–
(i) in preparation for external use containing 1% or less of boron; and
(ii) in unit dose preparations for peridontal disease containing 100 milligrams or less of boron
Bretylium
Bromethol
Bromhexine
Bromides, inorganic, for therapeutic use.
Bromine
Bromindione
Bromocryptine
Bromoform
Bromothen
Bromvaletone
Brucine and substances containing more than 0.2% of brucine.
Buclosamide
Bufexamac except when included in Schedule 2.
Bunamiodyl
Buphenine
Butyl Chloral Hydrate
Caffeine, its salts, except in substances and preparations containing 10%, or less of caffeine
Calcitonin
Calcium Bromidolactobionate
Calcium Carbimide
Calcium Disodium Versenate
Cannabis and Cannabis Resin and Extracts and Tinctures of Cannabis
Cantharides, its alkoloids, their salts, except in substances containing 0.1%, or less of cantharidin
Cantrodifine
Captodiame
Capuride
Carbarsone
Carbazochrome
Carbenoxolone except when included in Schedule 2.
Carbocromen
Carbomycine
Carbromal
Cardiac Glycosides not included elsewhere in this or any other Schedule
Catalin
Chloral Formamide
Chloral Hydrate and substances containing more than 5% of chloral hydrate
Chlorazanil
Chlorbutol, except in preparations containing 250 mgs or less per adult dosage unit
Chlorexolone
Chlorhexadol
Chlorisondamine
Chlormadinone
Chlormerodrin
Chlormethazanone
Chlormethiazole
Chloroform and substances containing more than 10% of chloroform
Chlorophacinone for therapeutic use
Chlorothianisen
Chlorphentermine
Chlorprothixene
Chlorthalidone
Chlorzoxazone
Choline Esters–both acyl and alkyl such as Acetylcholine, Carbachol, Methaline, Succinylcholine
Cinchophen
Clamoxyquin
Clefamide
Clioquinol
Clofenamide
Clofenoxine
Clofibrate
Clofibride
Clomacran
Clomipramine
Clonidine
Clonitazene
Clopamide
Clopidol
Cloponone
Clorozepate
Clorexolone
Clorgyline
Clostebol
Clothiapine
Clozapine
Coca Leaf
Cocaine (methyl ester of benzoylecgonine), and any solution or dilution in an inert substance whether liquid or solid in any proportion and all preparations and admixtures
Cocaine, synthetic substitutes for–except when included in Schedule 2
Codeine–
(i) in preparations in tablet or capsule form containing more than 10 mg of codeine in each such tablet or capsule; or
(ii) in any other substance containing more than 1% of codeine.
Codeine–Oxide
Colchicine and substances containing more than 0.5%, of colchicine
Coniine and substances containing more than 0.1%, of coniine
Convallaria
Corticotrophine and other pituitary hormones for parenteral use in humans, natural or synthetic and derivatives
Cortisone and steroid suprarenal cortical hormones and adreno-corticotropic hormone, either natural or synthetic, or their derivatives
Cotarnine
Coumarin derivatives and Phenylindanedione derivatives used as anticoagulants in the treatment of humans
Cromoglycic Acid
Cropropamide
Crotethamide
Cryptenamine
Curare, Tubocurarine, d-Tubocurarine-Dimethyl-Ether, and all synthetic quaternary ammonium compounds having curarising and ganglionic paralyzing effects including Polymethylene Bistrimethyl Ammonium compounds, Gallamine, Landexium Methyl Sulphate, Suxamethonium, Pentholinium, Mecamylamine, Pempidine and Trimethaphan except Atropine Methonitrate in preparations for external use
Cyclandelate
Cycloheximide
Cyclopentamine except when included in Schedule 2
Cytotoxic Substances with blood destroying and/or anti-cancer properties including Busulphan, Mustin and Tretamin
Danazol
Dangerous Drugs as defined in the Dangerous Drugs Act
Dantrolene
Deanol
Debrisoquine
Dehydroemetine
DET (N-N-Diethyltryptamine)
Dexbromphenimethdilazine
Dextran Sulphate
Dextromethorphan and its salts except preparations containing 1% or less
Dextropropoxyphene and its salts except preparations containing 1% or less
Dextrorphan and its salts except preparations containing 1% or less dextrorphan
Diamprodine
Diazepam
Diazoxide
Dibenzazepin
Dibutamide
Dichloralphenazone
Dichlorodiethyl Sulphide
Dichlorisone
Dichloroethane
Dichlorphenamide
Dicyclomine except in preparations containing 0.1% or less of dicyclomine
Diethylcarbamazine Citrate and other salts of diethylcarbamazine
Difenoxin
Digitalis, its glycosides and the derivatives of digitalis and its glycosides
Dihydrocodeine except in preparations containing 1% or less of dihydrocodeine
Di-Iodotyrosine
Di-Isopropylamine Dichloroacetate
Di-Isopropylamine Dichloroethanoate
Diloxanide
Dimepropion
Dimercaprol
Dimethoxanate
(-)-1-Dimethylamino-1, 2-Diphenylethane
Dimethyl Sulphoxide for therapeutic use
Dimophebumine
Dinitrocresols in medicinal preparations
Dinitronaphthols in medicinal preparations
Dinitrophenols in medicinal preparations
Dinitrothymols in medicinal preparations
Diodone
Dioxaphetyl Butyrate
Dipenine
Diphenadione
Diphenan
Diphenidol
Diphenoxylate
Dipyridamole
Dipyrone
Disopyramide
Distigmine
Disulfiram (except when used for industrial purposes)
Disulphamide
Dithiazanine Iodid
DMHP 3-(1, 2-dimethylheptyl)-1-hydroxy-7, 8, 9, 10 tetrahydro-6, 6, 9-trimethyl-6H-dibenzo b, 9 pyran
DMT (N-N-dimethyltryptamine)
Dothiepin
Doxapram
Doxepin
Ectyl Urea
Elaterium and its active principle elaterin
Emetine and its salts, except in preparations containing 0.2% or less of emetine
Ephedra, alkaloids of, both natural and synthetic including pseudoephedrine and their salts, except when included in Schedule 2
Ergot, its alkaloids, their salts, derivatives of such alkaloids, and their salts
Ethacrynic Acid
Ethchlorvynol
Ethebenecid
Ethinamate
Ethoheptazine
Ethomoxane
Ethoxzolamide
Ethyl Iodophenylundecylate
Ethyl Morphine in substances containing more than 1% of ethyl morphine
Etilefrine
Etiocholanolone
Fencamfamin
Fencamine
Fenclonine
Fenfluramine
Fenoterol
Flavodate
Flavoxate
Flucytosine
Flufenamic Acid
Flupenthixol
Flurazepam
Flurothyl
Fluspirilene
Frusemide
Fungacidin
Furalazine
Furazolidine
Fusafungine
Galantamine
Glucagon
Glutethimide
Glycopyrrolate
Glymidine
Gold Compounds for therapeutic use
Gonadotrophin
Guaiphenesin except when included in Schedule 2
Guanacline
Guancydine
Guanethidine
Guanoclor
Guanoxan
Heparin
Heptaminol
Heroin (diacetylmorphine)
Hexachlorophane except:–
(i) when included in Schedule 2 or in Schedule 5; or
(ii) in preparations containing 0.1% or less of hexachlorophane as a preservative
Hexafluoronium
Hexamethonium
Homatropine and substances containing more than 0.25% of homatropine
Hydrallazine
Hydrocyanic Acid, cyanides and substances containing more than the equivalent of 0.15% of hydrocyanic acid
8-Hydroxyquinoline and its derivatives for human use except when included in Schedule 2
Hyoscine and its derivatives in substances containing more than 0.25% of hyoscine or its derivatives
Hyoscine Butylbromide
Hyoscyamine and its derivatives in substances containing more than 0.25% of hyoscyamine or its derivatives
Hyoscyamus in substances containing more than 0.25% or alkaloids calculated as hyoscyamine
Ibufenac
Ibuprofen
Idoxuridine, except in preparations for cutaneous use
Indomethacin
Inositol Nicotinate
Iodoform, except in preparations for topical application containing 10% or less of iodoform
Iodothiouracil
Ion Exchange Resins for therapeutic use
Ioperamide
Iothalamic Acid
Iprindole
Iron, preparations for parenteral use
Isoaminile
Isoetharine
Isometheptene
Isoprenaline except when included in Schedule 2
Isoprophenamine
Jaborandi, alkaloids and their salts and substances containing more than 0.025% of the alkaloids
Ketamine
Khellin
Labetalol
Lepromin
Levamisole for human therapeutic use
Lidoflazine
Lithium Salts in preparation for human therapeutic use
Lobelia and in substances containing more than 0.5% of alkaloids, except for smoking and burning
Lofepramine
Loxapine
Lysergic Acid Diethylamide, its derivatives and lysergic acid
Lysuride
Mazindole
Mebeverine
Meclofenoxate
Mecloqualone
Mefenamic Acid
Mefenorex
Mefruside
Meglumine Iothalamate
Meladrazine
Melanin Stimulators including Ammoidin, Methoxsalen, Xanthotoxin
Melitracen
Mephenesin and its derivatives
Mephenoxalone
Mephentermine
Meraluride
Mercaptamine
Mercaptomerine
Mercuramide
Mercurous Chloride in substances for internal use
Mercury, salts and compounds–for parenteral use
Meso-inositol Hexamicotinate
Metaraminol Bitartrate
Metaxalone
Metazocine
Metformin
Methaphenilene
Methaqualone
Methazolamide
Methisazone
Methocarbamol
Methohexital
Methoserpidine
Methoxamine except for topical use
Methooxyphenamine
Methooxypromazine
Methylchromone
Methylcinchopen
Methyldopa
Methylhydrazine
Methyllicaconitine
Methyloctenylamine
Methylthiouracil
Methyprylone
Metoclopramide
Metolozone
Metronidazole
Metropolol
Metyrapone
Mexiletine
Mianserin
Miconazole
Molindone
Mono-amine Oxidase Inhibitors and all substances for which mono-amine oxidase inhibition is claimed
Monobenzone
Monophenylbutazone
Morphine, except in substances containing 0.2% or less calculated as anhydrous morphine
Morphine Antagonists
Morphine Derivatives not specifically mentioned elsewhere
Morphine Substitutes not specifically included in this Schedule
Muscarin
Myrophine
Nadide
Naftazone
Nalidixic Acid
Naftidrofuryl
Naloxone
Naproxen
Natamycin
Nefopam
Nedarsphenamine
Nicocodine, in substances containing more than 1%
Nicotinyl Alcohol for internal use
Nicoumalone
Nifenazone
Nimorazole
Niridazole
Nitrofuran and its derivatives for human therapeutic use
Nitroprussides for therapeutic use
Nomifensine
Nor-adrenaline, its salts, its n-alkyl derivatives, their salts, in concentrations of more than 1% of the base
Nylidrin
Nystatin
Octamylamine
Octaverin
Opipramol
Opium
Orciprenaline
Orphenadrine
Orthopterin
Ouabaine
Oxanamide
Oxethazine except:–
(i) in tablets containing 5 mg or less of oxethazine; or
(ii) in other preparations for ingestion containing 0.2% or less of oxethazine
Oxophenarsin
Oxpentifylline
Oxprenolol
Oxyfedrine
Oxypertine
Oxyphenbutazone
Oxyphenisatin
Papaverine
Parahexyl
Paraldehyde
Paraquat except when included in Schedule 3.
Pargyline
Paroxypropione
Pemoline
Pempidine
Penicillamine
Penicillinase
Pentamethonium
Pentazocine
Pentolinium
Perhexiline
Pethidine and all its derivatives
Phenacetin and all derivatives of Phenetidine except Paracetamol
Phenaglycodol
Phenazone for internal use
Phenazopyrodine
Phencyclidine
Phenformin
Pheniodol
Phenoxybenzamine
Phenprocoumon
Phentermine
Phentolamine
Phenoxypropazine
Phenylbutazone
Phenylcinchoninic Acid
Phenylhydrazine
Phenyramidol
Pholcodine and in substances containing more than 1% of pholcodine
Pholedrine
Pifenate
Pimozide
Pipamperone
Piperoxan
Pivhydrazine
Potassium Perchlorate for therapeutic use
Practolol
Prazosin
Prenylamine
Prindolol
Probenecid
Procainamide
Prolintane
Pronethalol
Propanidid
Propatylnitrate
Propiram
Propranolol
Propylhexedrine except when included in Schedule 2
Propylthiouracyl
Proscillinardin
Proscopine
Prostaglandins
Protokylol
Protoveratrine
Pyridine Aldoxime Methiodide
Quinapyramine
Quinethazone
Quinidine
Radioactive Substances for therapeutic use
Rauwolfia, its alkaloids, their salts, derivatives of such alkaloids, their salts
Rimeterol
Ritodrine
Salbutamol
Salmefamol
Santonin
Savin, oil of
Sex Hormones, natural or synthetic, their derivatives and substitutes having sex hormonal activity, in all preparations including cosmetics, not elsewhere specified in Schedule 4 and 5
Sparteine
Spironolactone
Stanozomel
Sodium Cromoglycate
Sodium Iothalamate
Sodium Metrizoate
Sotalol
Soterenol
Sodium Nitroprusside
Stramonium and substances containing more than 0.25% of alkaloids except for smoking or burning
Strophanthus and its glycosides and their derivatives
Strychnine and substances containing more than 0.2% of strychnine
Sulphanilamide and Sulphonamides, their salts, their derivatives, their salts, except when packed and labelled for veterinary use and except when incorporated in baits for the destruction of vermin
Sulphinpyrazone
Sulphonal and alkyl sulphonals
Sulpiride
Sultopiride
Sydrosingopine
Tansy, oil of
Techlothiazine
Terbutaline
Tetrabenazine
Tetrahydrocannabinol, including all isomers, salts and derivatives and all salts and derivatives of all isomers
Thalidomide
Thiazide and other substances for therapeutic use structurally derived from Benzothiadizine including Bendrofluazide Cyclopenthiazide, Hydrochlorothiazide
Thiocolchicoside
Thiothixene
Thorium Dioxide for human therapeutic use
Thyriod and its extract, and its active principal
Tiletamine
Timolol
Tinidazole
Tipepidine
Topenacin
Tolamolol
Tolazoline for internal use
Tolperisone
Tranexamic Acid
Trazodone
Triamterene
Trichomycin
Triclofos
Trimipramine and other compounds structurally derived from trimipramine
Trioxsalen
Triparanol
Trometamol
Tuaminoheptane except in solutions for topical use
Uracil Mustard
Urethanes and Ureides having or purporting to have soporific, or narcotic properties
Vaccines, sera, toroids, antitoxins and antigens for human use
Valnoctamide
Verapamil
Veratrum, its alkaloids, their salts
Viloxazine
Visnadine
Xanthine Oxidase inhibitors including Allopurinol
Xanthinol Nicotinate
Xanthocillin
N-(2, 3-xylyl Anthranilic Acid
Xylazine
Yohimba, its alkaloids, their salts
Any active principle, any natural or synthetic derivative, any salts and any compound of the substances specified in this Schedule and any preparation or admixture of such substances, active principals, derivatives, salts or compounds unless otherwise provided for in this or any other Schedule
Any substances not specifically included in this or any other Schedule which, if taken in a single dose of 60 mg or less, would be dangerous to human life
SCHEDULE 2 – [2]PRESCRIPTION POISONS.
Secs. 8, 17, 18, 19.
Acetarsol
Acetic Acid Glacial as such
Aconite in substances for internal use containing 0.02% or less of the alkaloids of aconite and liniments for external use containing 0.1% or less of the alkaloids of aconite
Adrenaline, natural or synthetic, its salts, in concentrations of more than 0.01% but not exceeding 1% of the base
Amodiaquine
Aminophylline
Amyl Nitrite
Antibiotics for topical application excluding preparations for otic and ophthalmic use in the form of creams, ointments or powders where only the following antibiotics may be used;
(i) Polymixin B Sulphate up to 5,000 Units per gram; or
(ii) Zinc Bacitracin up to 500 Units per gram; or
(iii) Neomycin Sulphate up to 5 mg per gram,
of the said creams, ointments or powders
Anaesthetics Local–the following only–Benzocaine, Butylcaine, Butylcaine Picrate, Orthocaine, Benamine Lactate, and Lignocaine, when included in:
(i) lozenges, pastilles, tablets and capsules containing 30 mg or less of such substance in each; or
(ii) suppositories or bougies containing 200 mg or less of such substance in each; or
(iii) preparations for external use, other than eye drops, containing 10% or less of such substances
Antihistamine substances (except Chlorcyclizine, Cyclizine, Meclozine, Methapyrilene and their salts and derivatives) in preparations labelled and packed solely for motion sickness in packs of 10 doses or less, in preparations for topical application, or in fluid preparations containing 0.75% or less of antihistamine substance
Antimony and substances containing more than the equivalent of 1% of antimony trioxide, except chlorides in polishes
Arnica and in all liquid substances
Arsenic and its chemical compounds except those included in Schedules 1 and 5
Aspartic Acid and its salts
Atropine in substances containing 0.25% or less of atropine
Atropine Methonitrate for external use
Barbituric Acid, its derivatives and their salts in substances containing 0.2% or less of barbituric acid, its derivatives or their salts
Belladonna in substances containing 0.25% or less of the alkaloids of belldonna, calculated as Hyoscyamine
Bephenium Hydroxynaphthoate
Bisacodyl
Bromide metallic, including ammonium, in medicinal preparations or admixtures containing more than 300mg of metallic bromide or ammonium bromide in each adult dose
Brucine in substances containing 0.2% or less of brucine except when used in concentrations of 0.02% or less for the denaturation of alcohol
Bufexamac in preparations for topical use containing 5% or less of bufexamac
Butenadiol-Bis-Methane Sulphonic Acid Ester
Camphorated Oil as such
Cantharides (Cantharidin) in substances containing 0.1% or less of cantharidin
Carbenoxolone for topical oral use
Chloral Hydrate in substances containing 5% or less of chloral hydrate
Chlorbutol in preparations containing 250 mg or less of chlorbutol per adult dosage unit
Chlordantoin
Chlorodyne
Chloroform in substances containing 1% or more but not more than 10% of chloroform
Chloroquine
Colchicine in substances containing 0.5% or less of colchicine
Coniine and substances containing 0.1% or less of coniine
Croton Oil
Cyclopentamine in solutions for topical use
Dexpanthenol
Dextromethorphan in substances containing 1% or less of dextromethorphan
Dextropropoxyphene in substances containing 1% or less of dextropropoxyphene
Dextrophan in substances containing 1% or less dextrophan
Dicophane (DDT) in preparations for human therapeutic use
Dicyclomine in preparations containing 0.1% or less of dicyclomine
Dihydrocodeine in preparations containing 1% or less of dihydrocodeine
Dihydroxyanthaquinone
Dimethisoquin
Dioctyl Sodium Sulphosuccinate
Diphemanil Methyl Sulphate in preparations for topical use
Ephedra, alkaloids of, both natural and synthetic and their salts including Pseudoephedrine and Methylephedrine in:–
(i) preparations containing 1% or less of the alkaloids; and
(ii) preparations containing pseudoephedrine in tablets or capsule form containing 60 mg or less of pseudoephdrine in each such capsule of tablet.
Erythrityl Teteranitrate and other nitric esters of polyhidric alcohols
Ether and substances containing more than 10% of ether
Ethyl Morphine in substances containing 1% or less of ethyl morphine
Fibrinolysin
Flavoxate
Fluorides, metallic, including ammonium fluoride, when intended for ingestion, except in dentifrices containing 0.5% or less
Gelsemium
Glyceryl Trinitrate
Griseofulvin
Guaiphenesin in liquid preparations containing 2% or less of guaiphenesin and in solid preparations containing 120 mg or less per dose form of guaiphenesin
Hexachlorophane in preparations for skin cleansing use containing 3% or less of hexachlorophane except in preparations for use on infants or in preparations containing 0.1% or less of hexachlorophane as a preservative
Homatropine in substances containing 0.25% or less of homatropine
Hydrocyanic Acid in substances containing 0.15% or less of hydrocyanic acid
8-Hydroxyquinoline and its derivatives for external human use
Hyoscine and its derivatives in substances containing 0.25% or less of hyoscyamine or its derivatives
Hyoscyamine and its derivatives in substances containing 0.25% or less of hyoscyamine or its derivatives
Hyoscyamus and its derivatives in substances containing 0.25% or less of alkaloids calculated as Hyoscyamine
Idoxuridine in preparations for cutaneous use only
Insulin and preparations containing the specific hypoglycaemic principle of the pancreas
Iodine in substances containing more than 2.5% but not more than 10% of iodine
Isoprenaline, its salts–
(i) in nebulizer solutions containing 1% or less of isoprenaline except in metered aerosols; or
(ii) in metered aerosols delivering 80 micrograms or less of isoprenaline per metered dose
Isopropamide in preparations containing 2% or less of isopropamide for tropical use
Isosorbide
Lead Salts and compounds of lead for medicinal use except in machine spread plasters
Levamisole
Lobelia in substances containing 0.5% or less of the alkaloids of lobelia and in preparations for smoking and burning
Lucanthone Hydrochloride
Maldison in preparations containing 2% or less of maldison for external use by humans
Mebendazole
Mercuric Ammonium Chloride
Mercuric Chloride and substances containing more than 0.5% of mercuric chloride except in batteries or when included in Schedule 5
Mercuric Iodine and substances containing more than 0.5% of mercuric iodine except when included in Schedule 5
Mercuric Nitrate and substances containing more than the equivalent of 3% of mercury (Hg), in such form
Mercuric Oxide and all oxides of mercury
Mercuric-potassium-iodide and substances containing more than the equivalent of 2% of mercuricpotassium-iodide, in such form
Mercury (metallic), as such
Mercury, organic compounds, and substances containing more than the equivalent of 0.5% of mercury (Hg), in organic combinations, except for therapeutic use or when included in Schedule 5
Metacresylacetate
Methenamine
Methylpolysiloxane
Morphine (except derivatives and their salts unless specifically included in this Schedule) in substances containing 0.2% or less of morphine calculated as anhydrous morphine
Naphazoline
Nicocodine in substances containing 1% or less nicocodine
Nor-adrenaline, its salts, is N-alkyl derivatives, their salts, in concentrations of over 0.01% but not exceeding 1% of the base
Noscapine
Nux Vomica
Octyl Nitrite
Oxalic Acid and metallic oxalates, except in laundry blue and polishes
Oxethazine when contained in tablets each containing 5 mg or less of oxethazine or in other preparations containing 0.2% or less of oxethazine
Oxolamine
Oxymetazoline
Pentaerythrityl Tetranitrate
Phenazone except for internal use
Phenol or its homologues boiling below 220°C as such
Phenylsalicylate
Phenylephrine
Phenylpropanolamine
Pholcodine in substances containing 1% or less of pholcodine
Phosphides Metallic
Phosphorus Yellow and in substances containing more than 0.5% of free phosphorus
Picric Acid and in substances containing more than 5% picric acid
Piperazine
Potassium Chlorate except in preparations containing 10% or less of potassium chlorate
Propantheline Bromide in preparations for topical use
Phopylhexedrine in approved appliances for inhalation in which the substance is suitably absorbed protected by inert solid material
Propylphenazone
Pyrantel for human therapeutic use
Quinine except in preparations containing less than 0.01% of quinine
Salicylamide
Selenium, salts and compounds except when included in Schedule 5
Sex Hormones . . . [Deleted]
Silver Nitrate except in caustic pencils containing not more than 500 mg of toughened silver nitrate
Silver Vitellin
Sodium Nitrate for therapeutic use
Sodium Nitrite for therapeutic use
Stavesacre
Stramonium in substances containing 0.25% or less of the alkaloids and in preparations for smoking and burning
Strychnine in substances containing 0.2% of strychnine or less
Tetrachlorethylene
Tetrahydrozaline
Theobromine
Theophylline
Thiabendazole
Tolpromazine
Tramazoline
Trichloroacetic Acid
Tuaminoheptane Sulphate in solutions for topical use
Tymazoline
Viprynium
Xylometazoline
Zinc, poisonous salts, except in substances containing 5% or less
Any compound preparation or admixture of the substances specified in this Schedule unless otherwise provided for in this or any other Schedule.
SCHEDULE 3 – POISONS FOR WHICH LICENCES MAY BE GRANTED.
[3]Secs. 5, 10,17, 18, 19.
Note This Schedule does not apply to a substance specified in it when contained in–
(a) batteries and accumulators; or
(b) ceramics; or
(c) electrical components and electrical lamps; or
(d) explosives; or
(e) fireworks other than fireworks containing arsenic; or
(f) glazes; or
(g) inorganic pigments; or
(h) matches; or
(i) motor fuels and lubricants; or
(j) paints other than substances prepared for medicinal or cosmetic purposes; or
(k) paper; or
(l) photographic paper; or
(m) propellants; or
(n) timber and wall board; or
(o) vitreous enamels.
Acetonyl Benzyl-4-Hydroxycomarin and in all substances containing more than 0.1%
Acrolein
Aldrin except when included in Schedule 5
Amines Aromatic, including Phenylene Diamine, Toluene Diamine and all other aromatic amines, when contained in hair Dyes
Ammonia and in preparations containing more than 5% of free ammonia (NH) except in medicinal substances for internal use, or when the substance is absorbed on an inert material
Anline except in substances containing 1% or less of anline
Aprocarb (R) except when included in Schedule 5
Azinphos-ethyl except when included in Schedule 5
Azinphos-methyl except when included in Schedule 5
Azodrin, except when included in Schedule 5
Beryllium
Beta-hydroxyethylhydrazine
Bidrin (R)
Carbon Bisulphide
Carbon Tetrachloride except when used for the treatment of humans or in fire extinguishers or in refill containers for such extinguishers
Carbophenothion except when included in Schedule 5
Chlorcam except when included in Schedule 5
Chlormequat
Chromic Acid, excluding its salts and derivatives
Cyanides for commercial purposes and in fumigants
Demeton except when included in Schedule 5
Dieldrin except when included in Schedule 5
Dimefox
Dimethan except when included in Schedule 5
Dimethyl Sulphoxide for non-therapeutic use
Dimetilan except when included in Schedule 5
Diphacinone in all substances containing more than 0.1% except for therapeutic purposes
Disulfoton except when included in Schedule 5
Endosulfan except when included in Schedule 5
Endrin except when included in Schedule 5
Fluoroacetic Acid, its salts and derivatives and all preparations and admixtures
Formaldehyde in substances containing more than 5% formaldehyde
Heptachlor and all other substitution or addition products of 4:7 Methanoindene except Chlordane except when included in Schedule 5
Hydrochloric Acid, excluding its salts and derivatives, in substances containing more than 10% of hydrochloric acid
Hydrofluoric Acid, Hydrosilicofluoric Acid, their salts and other fluorine compounds and all preparations except for therapeutic use and not specifically included in this or any other Schedule and except substances containing 3% or less of Sodium Fluoride and Sodium Silicofluoride when such are used as preservatives or in dentifrices containing less than 0.5% of Fluoride
Isobenzan except when included in Schedule 5
Isodrin except when included in Schedule 5
Kepone (R) except when included in Schedule 5
Lethane 384 (R) except when included in Schedule 5
Matacil (R) except when included in Schedule 5
Methidathion except when included in Schedule 5
Methiocarb (Mensurol) except when included in Schedule 5
Methomyl except when included in Schedule 5
Methyl Alcohol except in methylated spirits
Methyl Chloride
Methylene Chloride
Mevinphos
Nitric Acid, excluding its salts and derivatives, in substances containing more than 10% weight-in-weight of nitric acid
Nitrobenzene except in:–
(a) solid or semi-solid polishes; or
(b) soaps containing 1% or less of nitrobenzene; or
(c) any other substance containing 0.1% or less of nitrobenzene
Organophosphorus compounds having anticholinesterase activity except when included in any other Schedule
Paraquat in substances containing an emetic that–
(a) produces rapid and effective vomiting in man at low concentrations and with no adverse side effects; and
(b) is stable and would not affect the physical or chemical stability of the formulation; and
(c) does not adversely affect the herbicidal action of paraquat; and
(d) does not give rise to any adverse toxicological or environmental effects; and
(e) delays gastric emptying,
and a stenching substance that–
(f) is stable and would not affect the physical or chemical stability of the formulation; and
(g) does not adversely affect the herbicidal action of paraquat; and
(h) does not give rise to any adverse toxicological or environmental effects.
Parathion and Parathion-methyl
Pentachlorphenol except when included in Schedule 5
Phorate except when included in Schedule 5
Phosphamidon except when included in Schedule 5
Phosphoric Acid excluding its salts and derivatives, in substances containing more than 10% of phosphoric acid H3PO4.
Potassium Bromate except in substances containing 0.5% or less of potassium bromate
Propachlor
Prothoate except when included in Schedule 5
Pyrolan (R) except when included in Schedule 5
Rotenone except when included in Schedule 4 or 5
Sodium Arsenite except when included in Schedule 5
Sodium Bromate except in substances containing 0.5% or less of sodium bromate
Sodium Chlorate except in substances containing 50% or less of sodium chlorate
Strobane (R) except when including in Schedule 5
Sulphuric Acid and substances and preparations containing more than 35% weight-in-weight of sulphuric acid
Tetrachlorethane
Thallium and its salts, derivatives, compounds and all preparations and admixtures of Thallium
Zectran (R) except when included in Schedule 5.
SCHEDULE 4 – UNRESTRICTED DANGEROUS SUBSTANCES.
[4]Secs. 1, 11.
Note 1 A reference in this Schedule to a substance shall be deemed to include a reference to any compound preparation, or admixture containing any proportion of the substance, and these are therefore subject to all the restrictions of this Schedule, unless specifically exempted, or specifically included, in any other Schedule.
Note 2 This Schedule does not apply to a substance specified in it when contained in–
(a) batteries and accumulators; or
(b) ceramics; or
(c) electrical components and electrical lamps; or
(d) explosives; or
(e) fireworks other than fireworks containing arsenic; or
(f) glazes; or
(g) inorganic pigments; or
(h) matches; or
(i) motor fuels and lubricants; or
(j) paints other than substances prepared for medicinal or cosmetic purposes; or
(k) paper; or
(l) photographic paper; or
(m) propellants; or
(n) timber and wall board; or
(o) vitreous enamels.
Acetylene and calcium carbide
Allethrin
Ammonia, excluding its salts and derivatives other than ammonium hydroxide, in substances containing 5% or less of ammonia, except–
(a) in medicinal preparations for internal use; or
(b) in appliances for inhalation in which the substance is absorbed upon an inert solid material; or
(c) in substances containing 0.5% or less of ammonia.
Aramite (R)
Arsenate of lead.
Bromophos
Carbaryl
Chlorbenzilate
Chlordane
Chloropropylate
Chlorothion
Codeine in substances containing less than 1% of codeine.
Coloured chalks, crayons, school pastels, finger colours and show card colours containing any scheduled poison or dangerous substance.
DDT
Diazinon
Dichlorethylene
Dichlorpropane
Dichlorvos when impregnated in plastic resin material containing not more than 20% weight-in-weight of dichlorvos, or in aerosol formulations containing not more than 3% weight-in-weight of dichlorvos.
Dicofol
Disinfectants of cresol type, not elsewhere included.
Disinfectants of essential oil type.
Ethyl alcohol
Fenitrothion
Formaldehyde in substances containing 5% or less of formaldehyde, except in substances containing 0.5% or less of formaldehyde.
Formothion
Hydrocarbons, liquid, distilling under 300°C when tested according to method D86-61 of the American Society for Testing Materials, in substances containing more than 25% of such liquid hydrocarbons when packed in containers of 18.184 litres or less.
Hydrochloric acid, excluding its salts and derivatives, in substances containing 10% or less of hydrochloric acid except in substances containing 0.5% or less of hydrochloric acid.
Hydrogen peroxide in substances containing more than 6% weight-in-volume of hydrogen peroxide.
Iodine in liquid substances containing 2.5% or less of free iodine.
Iodophors containing 25% or less of free iodine.
Kerosene
Lindane
Maldison
Metaldehyde
Methoxychlor
Methylated spirits
Mineral turpentine in substances containing more than 25% of mineral turpentine when packed in containers of 18.184 litres or less.
Nitric acid, excluding its salts and derivatives, in substances containing 10% or less weight-in-weight of nitric acid.
Oil of turpentine in substances containing more than 25% of oil of turpentine when packed in containers of 18.184 litres or less.
Paints, dopes and varnishes containing a poisonous substance or solvent.
Paradichlorbenzene
Permanganates
Petrol in substances containing more than 25% of petrol when packed in containers of 18.184 litres or less.
Phenol, cresol, creosote and other homologues of phenol boiling below 220° C in substances containing 3% or less by weight of phenol, cresol, cresote and other homologues of phenol boiling below 220° C, except in preparations for medicinal use.
Phosphides, metallic
Phosphorus, yellow, in substances containing 0.5% or less of free phosphorus.
Picric acid, in substances containing 5% or less of picric acid.
Potassium hydroxide
Pyrethrins
Rotenone in substances containing not more than 3% weight-in-weight of rotenone.
Ryania
Sex Hormones when contained in the following ovulation inhibiting preparations for oral use:–
(i) pack of 21 tablets each containing a sex hormone; or
(ii) pack of 28 tablets; 21 containing a sex hormone and 7 containing an inert substance.
Sodium hydroxide
Sodium nitrite in substances containing more than 1% of sodium nitrite.
Thiourea
Thiram
Toluene
Trichlorphon
Xylene
Zinc, poisonous salts of, in substances containing less than 5% .
SCHEDULE 5 – AGRICULTURAL POISONS.
Secs. 1, 12.
Note The substances specified in this Schedule shall be packed, labelled and sold in accordance with Section 12.
Division I.[5]
Antibiotic premixes for growth promotion in animals containing any of the following substances as a total concentration of not more than 20,000 parts per million, when labelled with instructions for mixing into animal feeds to produce a total concentration of not more than 100 parts per million of antibiotic:–
(a) bacitracin
(b) benzylpenicillin, including procaine penicillin
(c) chlortetracycline
(d) erythromycin
(e) flavomycin
(f) hygromycin
(g) monensin
(h) nystatin
(i) oleandomycin
(j) oxytetracycline
(k) tylosin.
Anticoagulant substances, including substances structurally derived from coumarin, and phenindione and substances structurally derived from phenindione except where Schedule 1 applies.
Arecoline acetarsol in preparations for the treatment of hydatid infestation in animals.
Arsenic–
(a) in preparations for use as sheep or cattle drenches or as solutions for the treatment of foot rot; and
(b) in the forms of monosodium or disodium methyl arsenate in preparations for use as herbicides or defoliants.
Atropine sulphate when in tablets each containing 0.6 mg of atropine sulphate in packs of six tablets labelled with instructions for use in the treatment of poisoning by organophosphorous insecticides or carbamate insecticides.
Binapacryl
Bromoxynil
Butacarb
Chloramphenicol in topical preparations for the treatment of foot rot, and for ocular use in animals.
Chloroallyldiethyl thiocarbamate (CDEC)
2chloro-N: N-diallylacetamide (CDAA).
Chloropicrin
Chlortetracycline in preparations for the treatment of fish.
Chromates and dichromates of alkali metals and ammonium.
Chromic acid excluding its salts and derivatives.
Cronolone when impregnated in sponges for intra-vaginal use in sheep.
Di-allate
Dichlorethyl ether
Dichlorpropene
Dinocap
Diquat
Disulfiram except where Schedule 1 applies.
Dithianon
Ethyl bromide
Ethylene dibromide
Ethylene dichloride
Ethylene oxide
Ferbam
Hexachlorophane in preparations for the treatment of animals except in prepararions containing 0.1% or less of hexachlorophane as a preservative.
Hydrocyanic acid
Hydrogen phosphide
Ioxynil
Mercury, organic compounds, and substances containing more than the equivalent of 0.5% of mercury (Hg), in organic combinations.
Methyl bromide
Nicotine, except in substances containing 1% or less of nicotine and except in tobacco in any form.
Norbromide
Orthodichlorbenzene
Oxythioquinox
Penicillin, streptomycin, tetracycline, and substances structurally derived from penicillin, streptomycin or tetracycline when suitably coloured with brilliant blue FCF or other approved colour as a marker in preparations in applicator devices for intramammary infusion in the treatment of animals, and when the label indicates that they are for animal treatment only and contains a warning that when used in mastitis therapy the milk from treated animals must be discarded for 72 hours after cessation of therapy.
Prometryne
Selenium in substances containing 2.5% or less of selenium except for human therapeutic use.
Sulphanilamide and substances structurally derived from sulphanilamide in preparations for the treatment of animals.
Sulphaquinoxaline in baits for the destruction of vermin.
Sulphur dioxide, except when used as a food preservative.
Testosterone propionate and testosterone dipropionate in preparations for the treatment of animals.
Tetracycline and substances structurally derived from tetracycline in topical preparations for ocular use in animals or when packed in containers each containing not more than 1.2 g of tetracycline labelled with instructions for the treatment of aquarium fish or cage birds.
Tetrahydrofuran
Ziram
Division II.
Note The substances specified below, provided they are–
(a) labelled “for animal treatment or veterinary use only“; or
(b) in liquid formulations in packs containing not less than 4.546 litres; or
(c) in wettable powder formulations in packs of not less than 2.268 kg; or
(d) in dust formulations containing not more than 10% weight-in-weight of the substance in packs of not less than 25.402 kg; or
(e) in dry granulated materials in packs of not less than 25.402 kg:–
Aldrin
Aprocarb (R)
Azodrin
Chlorcam
Dieldrin
Dimethan
Dinitrocresols, dinirophenols and their homologues.
Endosulfan
Heptachlor and all other substitution or addition products of 4:7 methanoindene, except chlordane.
Kepone (R)
Lethane 384 (R)
Methiocarb (commercially known as Mensurol)
Organo phosphorus compounds having anti-cholinesterase activity, except when included in Schedule 4.
Pentachlorphenol
Pyrolan (R)
Rotenone, except when included in Schedule 4.
Sodium arsenite
Division III.
Note The substances specified below, provided they are in dry, granulated materials containing not more than 10% weight-in-weight of the substance and packed in containers of not less than 25 kg:–
Azinphos-ethyl
Azinphos-methyl
Carbophenothion
Demeton
Dimetilan
Disuhoton
Endrin
Isobenzan
Isodrin
Matacil (R)
Methidathion
Methomyl
Phorate
Phosphamidon
Prothoate
Strobane (R)
Zectran (R)
SCHEDULE 6 – LIQUID DANGEROUS SUBSTANCES.
Sec. 24.
Benzene
Benzine (petrol)
Kerosene
Methylated spirits (S.V.M.)
Mineral turps
Thinners
Turpentine
White spirit
Office of Legislative Counsel, PNG
PacLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.paclii.org/pg/legis/consol_act/padsa1952345
